Our Pipeline

NEXT ERA OF BIOLOGIC THERAPEUTICS

Bird Rock Bio’s novel antibody discovery platform (intramembranous Confirmation Antigen Presenting System)
was developed internally and led to the discovery of nimacimab. iCAPs is a platform that isolates G-protein coupled
receptors (GPCRs) in therapeutically relevant, stable conformations with minimal modifications to the GPCR protein.